Getting started
3-Bromo-5-(Trifluoromethyl)pyridine CAS 436799-33-6

3-Bromo-5-(Trifluoromethyl)pyridine CAS 436799-33-6 - China Manufacturers, Suppliers, Factory

3-Bromo-5-(Trifluoromethyl)pyridine CAS 436799-33-6, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
Paxlovid: what we know about Pfizer's Covid-19 pill

Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer...
Yellow phosphorus and phosphoric acid rose together

Yellow phosphorus and phosphoric acid rose together Yunnan-guizhou yellow phosphorus prices rose.Data show that the offer of 34500 yuan/ton at the beginning of the week has risen to 60,000 yuan/to...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

Eqiupment: GC instrument (Shimadzu GC-2010) Column: DB-17 Agilent 30mX0.53mmX1.0μm Initial oven temperature: 80℃ Initial time 2.0min Rate ...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...

2022.11.03 12:42:31
2022.10.07 20:15:44
2022.08.31 19:33:23
2022.08.14 12:54:45
2022.07.07 03:21:27
2022.06.21 02:56:55

3-Bromo-5-(Trifluoromethyl)pyridine CAS 436799-33-6 - China Manufacturers, Suppliers, Factory

Related Products

3-Bromo-5-(Trifluoromethyl)pyridine CAS 436799-33-6 Purity >98.0% (GC) Factory High Quality

Z-HomoPhe-OH CAS 127862-89-9 Assay ≥98.0% (HPLC)

Z-Hyp-OH CAS 13504-85-3 Purity ≥99.0% (HPLC)

Z-Ser-OH CAS 1145-80-8 N-Cbz-L-Serine Assay ≥99.0% (HPLC)

N-Cbz-N-Methyl-L-Isoleucine CAS 42417-66-3 Purity ≥98.0% (HPLC)

D-2-Cyanophenylalanine CAS 263396-41-4 Assay ≥98.0% (HPLC)

D-3-Cyanophenylalanine CAS 263396-43-6 Assay ≥98.0% (HPLC)

Top Selling Products

10-Deacetylbaccatin III CAS 32981-86-5 (10-DAB; 10-DB III) Assay 98.0~102.0%

Thulium(III) Trifluoromethanesulfonate CAS 141478-68-4 Purity >98.0% Tm 26.7~28.1% Complexometric Titration

trans-4-Amino-1-Adamantanol Hydrochloride CAS 62075-23-4 Purity >99.0% (GC)

Boc-Hyp-OMe CAS 74844-91-0 N-Boc-trans-4-Hydroxy-L-Proline Methyl Ester Purity >99.0% (HPLC) Factory

2-Phenyl-2-Oxazoline CAS 7127-19-7 Purity ≥99.0% Factory High Purity

Benzyl Carbazate CAS 5331-43-1 Purity >99.0% (HPLC)

Boc-Cys(pMeBzl)-OH CAS 61925-77-7 Purity >98.0% (HPLC) Factory

D-Glucal CAS 13265-84-4 Assay >96.0% (HPLC) Factory

Benzocyclobutenone CAS 3469-06-5 Purity >98.0% (GC)

L-Phenylalaninamide CAS 5241-58-7 (H-Phe-NH2) Purity >98.0% (HPLC)

2'-Hydroxyacetophenone CAS 118-93-4 Purity >99.0% (GC)

N-(Trimethylsilyl)imidazole (TSIM) CAS 18156-74-6 Purity >99.0% (GC) Factory Main Product

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

Paxlovid: what we know about Pfizer's Covid-19 pill

Yellow phosphorus and phosphoric acid rose together

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Test Method of (R)-(-)-3-Pyrrolidinol Hydrochloride CAS: 104706-47-0

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

2022.11.03 12:42:31

2022.10.07 20:15:44

2022.08.31 19:33:23

2022.08.14 12:54:45

2022.07.07 03:21:27

2022.06.21 02:56:55

related search